Stock of the Day

November 12, 2021

RenaissanceRe (RNR)

$322.88
+$7.62 (+2.4%)
Market Cap: $13.44B

About RenaissanceRe

RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. It distributes products and services primarily through intermediaries. The company invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.

Today's Trend

RenaissanceRe Holdings Ltd. (NYSE: RNR) is under mild pressure today after a wave of updated analyst forecasts from Zacks Research showed a mixed view on the insurer’s earnings outlook.

  • Zacks Research raised longer-term estimates, including FY2028 EPS to $44.01 from $42.80 and FY2026 EPS to $38.39 from $36.34, suggesting confidence in RenaissanceRe’s earnings power over time.
  • The firm also increased some near- and mid-term quarterly estimates, including Q3 2026 EPS to $4.77 from $4.62 and Q2 2027 EPS to $12.77 from $12.22, which could help support sentiment around future profitability.
  • Several other estimates were left around the consensus or changed only modestly, indicating analysts still expect RenaissanceRe to deliver strong earnings relative to the current full-year consensus of $39.08 per share.
  • At the same time, Zacks cut other forecasts, including FY2027 EPS to $39.94 from $41.00, Q1 2027 EPS to $11.15 from $11.90, Q4 2026 EPS to $8.87 from $9.78, and Q4 2027 EPS to $10.52 from $11.26, which may be weighing on the stock.
  • The mixed revisions may have created uncertainty about the pace of earnings growth, helping explain why RNR has been weaker as investors digest the revised outlook.

Overall, RNR looks lower because the recent analyst updates were not uniformly positive: some long-term estimates improved, but several important near-term and FY2027 forecasts were trimmed.

← Previous Stock of the DayNext Stock of the Day →

Recent News